Quentin_Massys_001 copyCurrent Funding

Like most academic labs in the United States, the majority of our financial support comes as project-specific, competitive grants from the National Institutes of Health. NIH grants are typically 3 to 5 years in duration. In addition we seek funding from private foundations that devote resources to research on specific topics, such as the American Foundation for AIDS Research or the American Cancer Society.

Our research program also welcomes donations from private individuals. If you are interested in supporting us please click this link.


Here’s a list of NIH grants to our lab that are currently active, with links to more detailed information about those projects:

1. The HUSH complex in HIV-1 latency

2. Insight into the Ebola virus glycoprotein fusion mechanism gleaned from the 2013-2016 epidemic GP-A82V variant.

3. Immunogenicity of human stem cell-derived beta cells and muscle cells in humanized mice

4. Mechanism of epigenetic inheritance in a mouse model of acute paternal stress. This is an NIH F30 Ruth L. Kirschstein Individual Predoctoral Fellowship awarded to Noah Silverstein.


Here’s a list of grant applications to the NIH that are pending, under review, or in preparation:

1. Epigenetic inheritance of resistance to pathogen-associated disease

2. The germline response to retroviral invasion

3. SERINC5 in HIV-1 replication, pathogenesis, and immunity


Here’s a list of some grants from the NIH that are no longer active, though some of these projects are still ongoing:

1. Rules of gene expression modeled on human dendritic cell response to pathogens

2. Boosting cell-intrinsic innate immune recognition of HIV-1 by dendritic cells

3. Human genes that influence HIV-1 replication, pathogenesis, and immunity

4. Next generation hybrid nucleases for precise excision of latent HIV-1 provirus

5. The interdependency of drug resistance evolution and drug design: HIV-1 Protease